Trimi vs Vaylen: Compounded Semaglutide Pricing, Formats, and Policies

Quick verdict: Trimi vs Vaylen

Trimi and Vaylen both sell compounded GLP-1 medication, but they differ in pricing models, product formats, and how you pay before clinician review. Trimi highlights flat per-dose pricing and free overnight shipping, while Vaylen advertises lower annualized rates on 12-month prepaid plans and an oral tablet option. Early verdict: choose Trimi if you want flat monthly pricing and overnight shipping; choose Vaylen if you want the lowest effective monthly rate on a prepaid 12-month plan or an oral tablet.

Start Trimi enrollment

Trimi vs Vaylen: headline differences

This comparison looks at five supported differences: price structure and billing, medication formats and molecules, refund and approval policies, shipping speed and fulfillment, and how clinician review and enrollment work. Every claim below comes from the supplied source evidence.

1. Price structure and billing

Trimi lists compounded semaglutide from $99 per month on an annual plan and tirzepatide at $125 per month, with a stated promise that the price stays the same as dose increases. Vaylen lists semaglutide from $83.25 per month on a 12-month plan or $224 per month month to month. Vaylen’s headline rates are annualized prices billed upfront in a single charge for the 12-month plan.

Start Vaylen enrollment

2. Medication formats and molecules

Both providers offer compounded semaglutide and tirzepatide. Vaylen explicitly offers three formats on one platform: weekly semaglutide injections, daily oral semaglutide tablets, and weekly tirzepatide, with oral semaglutide listed at $99 per month on the 12-month plan. Trimi focuses on compounded semaglutide and tirzepatide and emphasizes the active ingredients backed by peer-reviewed trials, while noting their compounded medications are not FDA-approved.

3. Refunds and approval policies

Vaylen requires prepayment for its 12-month pricing and states you pay before clinician review, but it offers a full refund for that billing cycle if a clinician declines to prescribe. Trimi advertises a 6-month money-back promise: follow the plan for 6 months and request a refund if you don’t lose weight, with terms applied, and also says you receive a 100% automatic refund if not approved by their medical team.

4. Shipping and fulfillment speed

Trimi advertises free overnight, temperature-controlled shipping. Vaylen advertises free discreet shipping in 1 to 3 business days. Both describe shipping as included, with Trimi emphasizing overnight delivery and Vaylen listing a 1 to 3 day window.

5. Clinician review and enrollment flow

Trimi states medications are prescribed by US-licensed clinicians through a clinical network led by a medical director and shipped from named compounding pharmacies. Vaylen uses licensed U.S. clinicians via OpenLoop Health, is LegitScript certified, and reviews health forms within 24 hours after prepayment. Vaylen is explicit that you pay first then the clinician reviews your file; Trimi presents a clinician review step and an automatic refund if not approved.

Comparison table: Trimi vs Vaylen

Criteria	Trimi	Vaylen
Starting price listed	Semaglutide from $99/mo on annual plan	Semaglutide from $83.25/mo on 12-month plan or $224/mo month to month
Price model	Flat pricing that never rises as dose increases; same price at every dose	Annualized 12-month prepaid rates or higher month-to-month rates
Formats offered	Compounded semaglutide and tirzepatide	Injectable semaglutide, oral semaglutide tablet, and tirzepatide
Refund if not approved	100% automatic refund if not approved by medical team	Full refund for that billing cycle if clinician declines
Shipping speed	Free overnight temperature-controlled shipping	Free discreet shipping in 1 to 3 business days
Clinician/payment flow	Clinician review and prescription through Arora Health network; membership covers medication and visits	Pay first, then clinician review within 24 hours; Clinician via OpenLoop Health
Regulatory note	Compounded medications are not FDA-approved	Compounded medications are not FDA-approved

How each provider frames risk and value

Trimi emphasizes flat pricing, named compounding pharmacies, a clinical leadership claim, and a 6-month money-back promise for weight loss results, while noting compounded medications are not FDA-approved. Vaylen emphasizes low annualized monthly rates on prepaid plans, a needle-free tablet option, a full refund when clinicians decline, and a faster clinician turnaround within 24 hours, while warning that headline rates require prepaying a full year.

Compare Trimi plans

Conclusion: choosing between Trimi and Vaylen

Trimi vs Vaylen comes down to whether you prefer flat, per-dose monthly pricing with overnight shipping and a stated automatic refund if not approved, or whether you prefer lower upfront annualized rates, a prepaid model, and an oral tablet option with a clinician refund if declined. Both sell compounded GLP-1 medications and both state that compounded medications are not FDA-approved.

Choose Trimi if you want flat pricing that does not increase with dose, free overnight temperature-controlled shipping, named compounding pharmacies, and an advertised automatic refund if not approved by the medical team.

Choose Vaylen if you want the lowest effective monthly rate on a prepaid 12-month plan, need an oral semaglutide tablet option, or prefer the explicit same-platform access to both injectable and tablet formats with a full refund if a clinician declines to prescribe.